Literature DB >> 8387773

Adrenergic control of the secretion of anterior pituitary hormones.

S al-Damluji1.   

Abstract

The hypothalamic hypophysiotrophic neurones are densely innervated by adrenergic and noradrenergic nerve terminals. Activation of alpha 1-adrenoceptors located in the brain stimulates the secretion of ACTH, prolactin and TSH. The effects of the alpha 1-adrenoceptors seem to be exerted on hypothalamic neurones that secrete vasopressin, CRH-41 and TRH. These mechanisms are important in the physiological control of the secretion of ACTH and TSH in humans. alpha 2-Adrenoceptors are not involved in the control of secretion of these hormones under basal conditions in humans. However, alpha 2-adrenoceptors exert an inhibitory effect that acts as a negative feedback mechanism, limiting excessive secretion of these hormones. There is no convincing evidence for the involvement of beta-adrenoceptors in the control of the secretion of these three hormones in humans. Studies on cultured anterior pituitary cells suggested that adrenaline and noradrenaline may influence the secretion of ACTH, prolactin and TSH directly at the level of the pituitary. However, these effects are not demonstrable in humans, and are likely to be due to alterations in the pituitary adrenoceptors during culture. In the case of growth hormone, activation of alpha 2-adrenoceptors located in the brain stimulates secretion of this hormone both by increasing the secretion of GHRH and by inhibiting the secretion of somatostatin. Activation of beta-adrenoceptors inhibits the secretion of growth hormone via an increase in the secretion of somatostatin. The effects of the central alpha 2- and beta-adrenoceptors are important in the physiological control of growth hormone secretion in humans. A considerable amount of evidence implicates brain alpha 1-adrenoceptors in the control of secretion of the gonadotrophins in experimental animals, but, despite intensive study, no convincing evidence has been found in humans of reproductive age.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8387773     DOI: 10.1016/s0950-351x(05)80180-6

Source DB:  PubMed          Journal:  Baillieres Clin Endocrinol Metab        ISSN: 0950-351X


  14 in total

1.  The atypical antipsychotics olanzapine and quetiapine, but not haloperidol, reduce ACTH and cortisol secretion in healthy subjects.

Authors:  Stefan Cohrs; Cornelia Röher; Wolfgang Jordan; Andreas Meier; Gerald Huether; Wolfgang Wuttke; Eckart Rüther; Andrea Rodenbeck
Journal:  Psychopharmacology (Berl)       Date:  2006-01-24       Impact factor: 4.530

Review 2.  The role of corticotropin-releasing factor and noradrenaline in stress-related responses, and the inter-relationships between the two systems.

Authors:  Adrian J Dunn; Artur H Swiergiel
Journal:  Eur J Pharmacol       Date:  2008-01-26       Impact factor: 4.432

3.  alpha(1B) adrenergic receptors in gonadotrophin-releasing hormone neurones: relation to Transport-P.

Authors:  S Al-Damluji; W B Shen; S White; E A Barnard
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

4.  Role of alpha-1-adrenergic receptors in the regulation of corticotropin-releasing hormone mRNA in the paraventricular nucleus of the hypothalamus during stress.

Authors:  A Kiss; G Aguilera
Journal:  Cell Mol Neurobiol       Date:  2000-12       Impact factor: 5.046

5.  Growth hormone responses to treadmill sprinting in sprint- and endurance-trained athletes.

Authors:  M E Nevill; D J Holmyard; G M Hall; P Allsop; A van Oosterhout; J M Burrin; A M Nevill
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

6.  Functional properties of the uptake of amines in immortalised peptidergic neurones (transport-P).

Authors:  S Al-Damluji; I J Kopin
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

7.  Binding and competitive inhibition of amine uptake at postsynaptic neurones (transport-P) by tricyclic antidepressants.

Authors:  S Al-Damluji; I J Kopin
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

8.  Quetiapine reduces nocturnal urinary cortisol excretion in healthy subjects.

Authors:  Stefan Cohrs; Kathrin Pohlmann; Zhenghua Guan; Wolfgang Jordan; Andreas Meier; Gerald Huether; Eckart Rüther; Andrea Rodenbeck
Journal:  Psychopharmacology (Berl)       Date:  2004-01-20       Impact factor: 4.530

9.  Increased plasma norepinephrine concentration in psychotic depression.

Authors:  Jaap G Goekoop; Remco F P de Winter; Ron Wolterbeek; Godfried M J Van Kempen; Victor M Wiegant
Journal:  Ther Adv Psychopharmacol       Date:  2012-04

10.  Chronic intermittent hypoxia sensitizes acute hypothalamic-pituitary-adrenal stress reactivity and Fos induction in the rat locus coeruleus in response to subsequent immobilization stress.

Authors:  S Ma; S W Mifflin; J T Cunningham; D A Morilak
Journal:  Neuroscience       Date:  2008-05-06       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.